Latest Myasthenia Gravis news
FDA Approves Zilbrysq for Generalized Myasthenia Gravis
posted October 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves First-in-Class Treatment for Myasthenia Gravis
posted December 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Thymectomy + PDN Beneficial for Non-Thymomatous Myasthenia Gravis 
Thymectomy Improves Outcomes in Myasthenia Gravis 
Autologous HSCT Can Result in Remission in Myasthenia Gravis Monthly Specialist Briefings
Stay Connected
